Makers Laboratories Ltd
Makers Laboratories is engaged in the business of Pharmaceuticals.
- Market Cap ₹ 124 Cr.
- Current Price ₹ 253
- High / Low ₹ 345 / 23.2
- Stock P/E
- Book Value ₹ 105
- Dividend Yield 0.00 %
- ROCE 1.80 %
- ROE -0.28 %
- Face Value ₹ 10.0
Pros
- No pros found. Suggest something.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -4.59% over past five years.
- Company has a low return on equity of 4.71% for last 3 years.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
13.50 | 14.18 | 14.36 | 10.13 | 7.96 | 10.25 | 17.36 | 11.25 | 12.54 | 9.14 | 13.67 | 10.48 | |
12.50 | 12.99 | 13.33 | 10.64 | 7.48 | 10.38 | 16.28 | 11.03 | 10.99 | 7.96 | 11.84 | 10.96 | |
Operating Profit | 1.00 | 1.19 | 1.03 | -0.51 | 0.48 | -0.13 | 1.08 | 0.22 | 1.55 | 1.18 | 1.83 | -0.48 |
OPM % | 7.41% | 8.39% | 7.17% | -5.03% | 6.03% | -1.27% | 6.22% | 1.96% | 12.36% | 12.91% | 13.39% | -4.58% |
Other Income | 0.45 | 0.48 | 0.59 | 0.54 | 0.97 | 0.04 | 0.07 | -0.02 | 0.13 | 0.19 | 0.11 | 0.05 |
Interest | 0.10 | 0.10 | 0.08 | 0.04 | 0.03 | 0.07 | 0.18 | 0.19 | 0.26 | 0.40 | 0.37 | 0.40 |
Depreciation | 0.40 | 0.36 | 0.37 | 0.38 | 0.39 | 0.38 | 0.51 | 0.48 | 0.62 | 1.00 | 1.02 | 1.08 |
Profit before tax | 0.95 | 1.21 | 1.17 | -0.39 | 1.03 | -0.54 | 0.46 | -0.47 | 0.80 | -0.03 | 0.55 | -1.91 |
Tax % | 14.74% | 20.66% | 20.51% | 43.59% | 24.27% | -14.81% | 30.43% | 68.09% | 58.75% | 166.67% | -70.91% | 4.71% |
Net Profit | 0.81 | 0.96 | 0.94 | -0.23 | 0.79 | -0.62 | 0.32 | -0.15 | 0.33 | 0.02 | 0.94 | -1.83 |
EPS in Rs | 1.65 | 1.95 | 1.91 | -0.47 | 1.61 | -1.26 | 0.65 | -0.31 | 0.67 | 0.04 | 1.91 | -3.72 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
42.29 | 46.26 | 54.04 | 62.41 | 61.55 | 68.37 | 64.91 | 61.41 | 58.13 | 55.95 | 46.60 | 51.31 | 45.83 | |
38.07 | 40.97 | 47.73 | 61.31 | 57.68 | 65.93 | 60.77 | 56.72 | 52.92 | 51.30 | 44.38 | 48.60 | 41.75 | |
Operating Profit | 4.22 | 5.29 | 6.31 | 1.10 | 3.87 | 2.44 | 4.14 | 4.69 | 5.21 | 4.65 | 2.22 | 2.71 | 4.08 |
OPM % | 9.98% | 11.44% | 11.68% | 1.76% | 6.29% | 3.57% | 6.38% | 7.64% | 8.96% | 8.31% | 4.76% | 5.28% | 8.90% |
Other Income | 0.13 | 0.23 | 0.62 | 0.54 | 1.59 | 0.21 | 1.18 | 0.42 | 1.47 | 1.52 | 2.56 | 0.23 | 0.48 |
Interest | 0.54 | 0.69 | 1.09 | 1.27 | 0.96 | 0.49 | 0.39 | 0.36 | 0.27 | 0.36 | 0.26 | 0.70 | 1.43 |
Depreciation | 0.13 | 0.18 | 0.70 | 1.02 | 1.01 | 0.97 | 1.53 | 1.25 | 1.08 | 1.57 | 1.50 | 1.99 | 3.72 |
Profit before tax | 3.68 | 4.65 | 5.14 | -0.65 | 3.49 | 1.19 | 3.40 | 3.50 | 5.33 | 4.24 | 3.02 | 0.25 | -0.59 |
Tax % | 35.05% | 39.78% | 32.68% | 12.31% | 30.09% | 50.42% | 30.88% | 34.29% | 30.77% | 27.83% | 18.87% | 148.00% | |
Net Profit | 2.39 | 2.80 | 3.46 | -0.57 | 2.44 | 0.60 | 2.35 | 2.31 | 3.70 | 3.06 | 2.45 | -0.12 | -0.54 |
EPS in Rs | -1.16 | 4.96 | 1.22 | 4.78 | 4.70 | 7.52 | 6.22 | 4.98 | -0.24 | -1.10 | |||
Dividend Payout % | 0.00% | 15.54% | 14.22% | 0.00% | 0.00% | 0.00% | 20.94% | 21.30% | 13.30% | 16.08% | 20.08% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 1% |
5 Years: | -5% |
3 Years: | -4% |
TTM: | -2% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -259% |
Stock Price CAGR | |
---|---|
10 Years: | 23% |
5 Years: | 30% |
3 Years: | 47% |
1 Year: | 582% |
Return on Equity | |
---|---|
10 Years: | 7% |
5 Years: | 6% |
3 Years: | 5% |
Last Year: | -0% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4.35 | 4.35 | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 | |
Reserves | 7.49 | 9.78 | 15.52 | 14.95 | 17.39 | 17.99 | 19.71 | 21.42 | 29.15 | 31.90 | 36.78 | 39.70 | 46.88 |
Borrowings | 7.50 | 11.58 | 10.97 | 8.02 | 4.40 | 2.12 | 0.80 | 0.18 | 1.43 | 1.29 | 6.38 | 13.05 | 11.57 |
4.00 | 4.87 | 6.96 | 10.20 | 12.04 | 15.99 | 13.67 | 13.68 | 14.70 | 15.18 | 11.94 | 16.20 | 20.74 | |
Total Liabilities | 23.34 | 30.58 | 38.37 | 38.09 | 38.75 | 41.02 | 39.10 | 40.20 | 50.20 | 53.29 | 60.02 | 73.87 | 84.11 |
3.08 | 6.20 | 12.12 | 12.38 | 12.26 | 11.94 | 11.47 | 10.39 | 17.30 | 16.62 | 18.10 | 32.89 | 31.56 | |
CWIP | 0.77 | 0.13 | 0.00 | 0.00 | 0.01 | 1.92 | 2.71 | 4.23 | 0.15 | 0.11 | 6.42 | 0.69 | 0.74 |
Investments | 4.87 | 4.40 | 4.60 | 4.60 | 4.04 | 2.50 | 2.35 | 2.35 | 7.12 | 9.18 | 11.16 | 15.04 | 23.45 |
14.62 | 19.85 | 21.65 | 21.11 | 22.44 | 24.66 | 22.57 | 23.23 | 25.63 | 27.38 | 24.34 | 25.25 | 28.36 | |
Total Assets | 23.34 | 30.58 | 38.37 | 38.09 | 38.75 | 41.02 | 39.10 | 40.20 | 50.20 | 53.29 | 60.02 | 73.87 | 84.11 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
4.23 | 0.95 | 5.99 | 2.79 | 1.01 | 1.30 | 1.32 | 3.52 | 5.53 | 0.21 | 5.39 | 4.23 | |
-3.80 | -2.67 | -3.41 | -0.88 | 0.81 | -1.12 | -1.00 | -1.49 | -2.96 | -2.06 | -8.31 | -8.43 | |
-0.52 | 1.73 | -1.94 | -2.25 | -1.85 | -0.45 | -0.38 | -0.91 | 0.39 | -1.09 | 3.92 | 2.91 | |
Net Cash Flow | -0.09 | 0.01 | 0.64 | -0.34 | -0.03 | -0.27 | -0.06 | 1.12 | 2.96 | -2.95 | 1.00 | -1.29 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 25.29% | 23.93% | 21.81% | 2.26% | 12.82% | 7.81% | 13.08% | 15.63% | 15.54% | 13.15% | 7.63% | 1.80% |
Debtor Days | 43.50 | 53.18 | 48.02 | 43.04 | 58.59 | 66.89 | 66.58 | 85.65 | 75.73 | 73.20 | 39.32 | 53.71 |
Inventory Turnover | 4.62 | 4.34 | 4.45 | 4.93 | 3.98 | 4.60 | 4.47 | 5.09 | 5.13 | 3.49 | 2.42 | 2.79 |
Documents
Add documentRecent announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 11 Feb
- Unaudited Standalone & Consolidated Financial Results Along With Limited Review Reports Of The Company''s Auditors Thereon For The 3Rd Quarter And Nine Months Ended 31St December, 2020 10 Feb
- Unaudited Standalone & Consolidated Financial Results Along With Limited Review Reports Of The Company''s Auditors Thereon For The 3Rd Quarter And Nine Months Ended 31St December, 2020 10 Feb
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 3 Feb
- Company''s New Ophthalmic/Eye Drops Manufacturing Unit At GIDC, Naroda, Ahmedabad 2 Feb
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2012 from bse
- Financial Year 2011 from bse
- Financial Year 2010 from bse